Display options
Cite
Boyle DA. Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia Pac J Oncol Nurs. 2017;4(2):98-103doi: 10.4103/2347-5625.204497.
Boyle, D. A. (2017). Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia-Pacific journal of oncology nursing, 4(2), 98-103. https://doi.org/10.4103/2347-5625.204497
Boyle, Deborah A. "Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses." Asia-Pacific journal of oncology nursing vol. 4,2 (2017): 98-103. doi: https://doi.org/10.4103/2347-5625.204497
Boyle DA. Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia Pac J Oncol Nurs. 2017 Apr-Jun;4(2):98-103. doi: 10.4103/2347-5625.204497. PMID: 28503639; PMCID: PMC5412161.
Copy Download .nbib Format: NLM
Share it on

Asia Pac J Oncol Nurs. 2017 Apr-Jun;4(2):98-103. doi: 10.4103/2347-5625.204497.

Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses.

Asia-Pacific journal of oncology nursing

Deborah A Boyle

Affiliations

  1. Advanced Oncology Nursing Resources, Inc., Huntington Beach, CA, USA.

PMID: 28503639 PMCID: PMC5412161 DOI: 10.4103/2347-5625.204497

Abstract

Hepatocellular carcinoma (HCC) is a prominent malignancy in the Asia-Pacific region. Despite considerable knowledge about it's scope and nature this malignancy remains incurable. This manuscript reviews the epidemiology of this cancer, its pathogenesis, risk factors, potential prevention, surveillance, treatment, and the oncology nurses' role relative to this malignancy. A literature search from the past decade was performed using the PubMed and CINAHL databases using the search terms "hepatocellular carcinoma," "Asia," and "nursing issues". Themes such as etiology, prevention, treatment, and prognosis were included in this synthesis which has particular relevance to oncology nurses within the Asia-Pacific region.

Keywords: Hepatocellular cancer; nursing interventions; oncology nurses’ role

Conflict of interest statement

There are no conflicts of interest.

References

  1. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
  2. Lancet Oncol. 2009 Nov;10(11):1111-8 - PubMed
  3. Liver Cancer. 2016 Jul;5(3):190-7 - PubMed
  4. N Engl J Med. 1997 Dec 11;337(24):1733-45 - PubMed
  5. J Gastroenterol Hepatol. 2011 Dec;26(12):1779-86 - PubMed
  6. Gut Liver. 2016 May 23;10 (3):332-9 - PubMed
  7. J Cancer. 2013 Sep 14;4(8):635-43 - PubMed
  8. Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2362-8 - PubMed
  9. Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14 - PubMed
  10. Ann Oncol. 2016 Aug;27(8):1467-74 - PubMed
  11. J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S34-42 - PubMed
  12. World J Hepatol. 2015 Jun 18;7(11):1521-9 - PubMed
  13. Korean J Intern Med. 2014 Mar;29(2):149-55 - PubMed
  14. Cancer Manag Res. 2017 Feb 09;9:19-27 - PubMed
  15. J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11 - PubMed
  16. World J Gastroenterol. 2014 Apr 21;20(15):4115-27 - PubMed
  17. Semin Oncol. 2015 Apr;42(2):309-15 - PubMed
  18. CA Cancer J Clin. 2015 Mar;65(2):87-108 - PubMed
  19. World J Hepatol. 2015 Jun 28;7(12):1708-17 - PubMed
  20. Cancer. 2014 Sep 15;120(18):2824-38 - PubMed
  21. J Gastroenterol Hepatol. 2010 Apr;25(4):657-63 - PubMed
  22. Biosci Trends. 2010 Dec;4(6):283-7 - PubMed
  23. Oncologist. 2011;16(3):310-8 - PubMed
  24. J Gastroenterol Hepatol. 2009 Mar;24(3):346-53 - PubMed
  25. Hepat Mon. 2016 Mar 06;16(3):e35106 - PubMed
  26. Aust N Z J Public Health. 2004 Jun;28(3):212-6 - PubMed
  27. Clin Mol Hepatol. 2016 Mar;22(1):7-17 - PubMed

Publication Types